Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Gene Express, a molecular diagnostic company, has entered into a distribution agreement with Biogenuix Medsystems, a provider of contract research organization solutions, for the distribution of Gene Express's Standardized RT-PCR reagents and research molecular diagnostic tools.
Subscribe to our email newsletter
The non-exclusive agreement provides Biogenuix with the rights to distribute in India.
Among the standardized RT-PCR (StaRT-PCR) based research molecular tools are kits for chronic myelogenous leukemia, lung cancer risk prediction and inflammation/rheumatoid arthritis. The reagents include a selection of more than 600 StaRT-PCR internal standards.
Jonathan Rowe, COO of Gene Express, said: “This will be the first time that Gene Express’s patented standardized gene expression technology will be made widely available to Indian researchers. By partnering with a valuable partner in Biogenuix, we are confident that the Gene Express tests and reagents will be widely accepted in the Indian research market.”